Common clinical indications

• Primary prophylaxis of Mycobacterium avium complex (MAC) disease in HIV-infected patients at high risk, when recommended by current HIV guidelines.
• Secondary prophylaxis (chronic maintenance therapy) to prevent recurrence of MAC disease in HIV-infected patients (in combination with ethambutol and a macrolide).
• Treatment of active MAC disease as part of a multidrug regimen.
• Adjunct in tuberculosis treatment regimens in patients receiving interacting antiretroviral therapies (per TB/HIV guidelines; not detailed here).

Related drugs in this category

• Pyrazinamide · Pyrazinamide

Frequently asked questions

What is Rifabutin used for?

Rifabutin (Rifabutin) is listed in YMed Atlas under Antituberculous agent. Indications, dosing, and safety information on this page summarize curated references—always confirm with current labeling, formularies, and local protocols.

How do I adjust dosing for renal impairment or special populations?

Review the dosing sections and references for this monograph. Many agents require renal or hepatic adjustment; pediatric, pregnancy, and lactation considerations are clinician-specific. This interface is educational and does not replace individualized prescribing decisions.

Is this medical advice?

No. YMed Atlas drug pages support learning and quick reference. They are not a substitute for clinical judgment, pharmacist review, or formal interaction checking with a complete medication list.